QA Testing

download/print PDF version
reload without photo
PharmLabs San Diego Certificate of Analysis
Sample Distillate
Delta9 THC 16.02% THCa ND Total THC (THC + THCa) 16.02% Delta8 THC 55.15%
Logo_coa
Sample ID  SD220330-015 (47518) Matrix   Concentrate (Inhalable Cannabis Good)
Tested for  DC Studio
Sampled   - Received   Mar 30, 2022 Reported   Mar 31, 2022
Analyses executed   CAN+

CAN+ - Cannabinoids

Analyzed Mar 31, 2022  |  Instrument HPLC-VWD  | Method SOP-001
The expanded Uncertainty of the Cannabinoid analysis is approximately ±7.806% at the 95% Confidence Level
Analyte   LOD
mg/g
LOQ
mg/g
Result
%
Result
mg/g
Cannabidivarin (CBDV)   0.039 0.16 ND ND
Cannabidiolic Acid (CBDA)   0.001 0.16 ND ND
Cannabigerol Acid (CBGA)   0.001 0.16 ND ND
Cannabigerol (CBG)   0.001 0.16 0.31 3.09
Cannabidiol (CBD)   0.001 0.16 0.42 4.17
Tetrahydrocannabivarin (THCV)   0.001 0.16 0.17 1.68
Cannabinol (CBN)   0.001 0.16 0.40 3.99
Tetrahydrocannabinol (Δ9-THC)   0.003 0.16 16.02 160.20
Δ8-tetrahydrocannabinol (Δ8-THC)   0.004 0.16 55.15 551.55
Cannabicyclol (CBL)   0.002 0.16 0.15 1.51
Cannabichromene (CBC)   0.002 0.16 0.28 2.79
Tetrahydrocannabinolic Acid (THCA)   0.001 0.16 ND ND
Total THC ( THCa * 0.877 + Δ9THC )       16.02 160.20
Total THC + Δ8THC ( THCa * 0.877 + Δ9THC + Δ8THC )       71.17 711.75
Total CBD ( CBDa * 0.877 + CBD )       0.42 4.17
Total CBG ( CBGa * 0.877 + CBG )       0.31 3.09
Total Cannabinoids Analyzed       72.90 728.99